| Literature DB >> 28204873 |
Anamaria Girbovan1, Genel Sur2,3, Gabriel Samasca4,5, Iulia Lupan6.
Abstract
Celiac disease remains one of the most challenging pathologies of the small intestine. It involves multiple pathogenic pathways and there are no disease-changing pharmacological agents available against it yet. The term microbiota refers to the community of microorganisms that inhabit a particular region of the body. Normal gut microbiota has a vital role in maintaining the intestinal homeostasis and promoting health. Celiac disease is associated with microbiota alteration, especially with an increase in the number of Gram-negative bacteria and a decrease in the number of Gram-positive bacteria. There is a strong relationship between intestinal dysbiosis and celiac disease, and recent studies are aimed at determining whether the celiac disease is a risk factor for dysbiosis or dysbiosis is for celiac disease. Therefore, the aim of this review was to assess the latest findings regarding the gut microbiota and its impact on the celiac disease, including therapeutic aspects.Entities:
Keywords: Celiac disease; Dysbiosis; Intestinal microbiota; Probiotics
Mesh:
Substances:
Year: 2017 PMID: 28204873 DOI: 10.1007/s00430-017-0496-z
Source DB: PubMed Journal: Med Microbiol Immunol ISSN: 0300-8584 Impact factor: 3.402